Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators

Figure 2

In subjects (% of group) with previous laboratory investigations available, no significant difference in (a) alanine aminotransferase, (b) alanine aspartate aminotransferase, (c) alkaline phosphatase, (d) total bilirubin, or (e) platelet count was detected in subjects with elevated liver stiffness measurement (cirrhosis versus normal, Mann–Whitney tests, ).

(a)

(b)

(c)

(d)

(e)